Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
Pulczynski EJ, Simonsen MR, Kuittinen O, Fagerli UM, Erlanson M, Fluge Ø, Leppä S, Østenstad B, Fosså A, Eriksson M, El-Galaly T, Kuitunen H, Papworth K, Ljungqvist M, Pedersen MB, Pollari M.
Pulczynski EJ, et al. Among authors: papworth k.
Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2024.285207. Online ahead of print.
Haematologica. 2024.
PMID: 38546689
Free article.